Johns Hopkins Kimmel Cancer Center
Tracked across 2 events · 28 articles · First seen Jul 16, 2026 · Last active Aug 07, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Lead research institution; validated the AI blood test, enhancing its reputation and potential for commercial partnerships.
Jul 31, 2026 · 7 articles
Tech
A phase 1 clinical trial of mKRAS-VAX, an investigational vaccine targeting six common KRAS mutations, demonstrated safety and durable immune responses in 18 of 20 high-risk individuals for pancreatic ductal adenocarcinoma (PDAC). The vaccine, developed…
Impact: Affiliated institution of the lead researchers; central to the trial's execution and reputation.
Jul 16, 2026 · 21 articles
90
Johns Hopkins Kimmel Cancer Center developed vaccinePancreatic Cancer Vaccine...
85
Johns Hopkins Kimmel Cancer Center conducted trialPancreatic Cancer Vaccine...
80
Johns Hopkins Kimmel Cancer Center published findingsPancreatic Cancer Vaccine...
80
Johns Hopkins Kimmel Cancer Center reported immune responsePancreatic Cancer Vaccine...
70
Johns Hopkins Kimmel Cancer Center observed cyst regressionPancreatic Cancer Vaccine...
ERGEN INTELLIGENCE
Track Johns Hopkins Kimmel Cancer Center live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard